Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 17/20 | 1.00 |
| ▸ | MTNR1B | P49286 | 16/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 4/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 4/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 4/20 | 1.00 |
| ▸ | HTR2B | P41595 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | THPO | P40225 | 1/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.76 |
| ▸ | HPGD | P15428 | 3/20 | 0.76 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.76 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29424273 | 1.00 | MTNR1A (1.00) | MTNR1AMTNR1BCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL26187597 | 0.93 | MTNR1A (0.87) | MTNR1AMTNR1BCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL1773582 | 0.90 | MTNR1A (1.00) | MTNR1AMTNR1BCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL11619446 | 0.89 | MTNR1A (0.80) | MTNR1AMTNR1BCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL7891034 | 0.88 | MTNR1A (0.79) | MTNR1AMTNR1BCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL9119776 | 0.87 | MTNR1A (0.77) | MTNR1AMTNR1BCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL29575897 | 0.86 | MTNR1A (1.00) | MTNR1AMTNR1BCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL674970 | 0.86 | MTNR1A (1.00) | MTNR1AMTNR1BCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL8041780 | 0.86 | MTNR1A (0.83) | MTNR1AMTNR1BCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL6949528 | 0.85 | MTNR1A (0.81) | MTNR1AMTNR1BCYP1A2CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 349 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108699056-A | Method for treating atopic dermatitis | 江伯伦 | 2018-10-23 | — | — | CN | claimed |
| US-20180296530-A1 | METHOD FOR TREATING ATOPIC DERMATITIS | CHIANG BOR LUEN (TW) | 2018-10-18 | — | — | US | claimed |
| WO-2017107567-A1 | METHOD FOR TREATING ATOPIC DERMATITIS | CHIANG BOR-LUEN (CN) | 2017-06-29 | — | — | WO | claimed |
| US-20160008325-A1 | ISCHEMIA/REPERFUSION PROTECTION COMPOSITIONS AND METHODS OF USING | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-01-14 | — | — | US | claimed |
| WO-2012170599-A1 | NEUROGENESIS BY MUSCARINIC RECEPTOR MODULATION | BRAINCELLS, INC. (US) | 2012-12-13 | — | — | WO | claimed |
| WO-2012154807-A1 | USE OF JASMONATES FOR MODULATING MELATONIN PRODUCTION AND CALCIFICATION OF THE PINEAL GLAND | BROADY HEALTH SCIENCES, LLC (US) | 2012-11-15 | — | — | WO | claimed |
| US-20120288485-A1 | USE OF JASMONE FOR MODULATING MELATONIN PRODUCTION AND CALCIFICATION OF THE PINEAL GLAND | Broady Health Sciences, LLC. (US) | 2012-11-15 | — | — | US | claimed |
| US-20110319386-A1 | NEUROGENESIS BY MUSCARINIC RECEPTOR MODULATION | BRAINCELLS INC. (US) | 2011-12-29 | — | — | US | claimed |
| EP-2275095-A2 | Neurogenesis by muscarinic receptor modulation | Braincells, Inc. (US) | 2011-01-19 | — | — | EP | claimed |
| EP-2275096-A2 | Neurogenesis via modulation of the muscarinic receptors | Braincells, Inc. (US) | 2011-01-19 | — | — | EP | claimed |
| WO-2005063240-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF HYPERTENSION | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2005-07-14 | — | — | WO | claimed |
| US-20050137247-A1 | Methods and compositions for treatment of hypertension | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2005-06-23 | — | — | US | claimed |
| CN-1177978-A | Stimulation of meiosis | NOVO NORDISK AS (DK) | 1998-04-01 | — | — | CN | claimed |
| EP-0813595-A1 | STIMULATION OF MEIOSIS | NOVO NORDISK A/S (DK) | 1997-12-29 | — | — | EP | claimed |
| EP-0513702-B1 | Melatonin derivaties for use in the therapy of sleep disorders and in pre-anaesthetic medication | I F L O ISTITUTO FARMACOLOGICO (IT) | 1996-09-18 | — | — | EP | claimed |
| WO-1996027658-A1 | STIMULATION OF MEIOSIS | NOVO NORDISK A/S (DK) | 1996-09-12 | — | — | WO | claimed |
| US-5430029-A | Pharmaceutical compositions active in the therapy of sleep disorders | IFLO-ISTITUTO FARMACOLOGICO LOMBARDO S.A.S. DI GIORGIO E ALD. LAGUZZI (IT) | 1995-07-04 | — | — | US | claimed |
| EP-0513702-A2 | Melatonin derivaties for use in the therapy of sleep disorders and in pre-anaesthetic medication | I.F.L.O. ISTITUTO FARMACOLOGICO LOMBARDO S.A.S. di Giorgio & Aldo Laguzzi & C. (IT) | 1992-11-19 | — | — | EP | claimed |
| US-4997845-A | β-alkylmelatonins as ovulation inhibitors | ELI LILLY AND COMPANY (US) | 1991-03-05 | — | — | US | claimed |
| US-4882137-A | MELATONIN | GENE LINK AUSTRALIA LIMITED (AU) | 1989-11-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319386-A1 | NEUROGENESIS BY MUSCARINIC RECEPTOR MODULATION | CHRNB2, CHAT, CHRNB4 | MTNR1A 51/4885MTNR1B 70/4885CYP1A2 4444/4885 |
| US-20050137247-A1 | Methods and compositions for treatment of hypertension | REN, MTNR1A, MTNR1B | MTNR1A 2/4885MTNR1B 3/4885CYP1A2 914/4885 |
| US-20180296530-A1 | METHOD FOR TREATING ATOPIC DERMATITIS | MTNR1A, MTNR1B, TSLP | MTNR1A 1/4885MTNR1B 2/4885CYP1A2 518/4885 |
| US-20120288485-A1 | USE OF JASMONE FOR MODULATING MELATONIN PRODUCTION AND CALCIFICATION OF THE PINEAL GLAND | MTNR1A, NLN, MTNR1B | MTNR1A 1/4885MTNR1B 3/4885CYP1A2 2079/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.